342 related articles for article (PubMed ID: 27927793)
21. Epigenome Remodeling in Cholangiocarcinoma.
O'Rourke CJ; Lafuente-Barquero J; Andersen JB
Trends Cancer; 2019 Jun; 5(6):335-350. PubMed ID: 31208696
[TBL] [Abstract][Full Text] [Related]
22. Epigenetics in Hematological Malignancies.
Cruz-Rodriguez N; Combita AL; Zabaleta J
Methods Mol Biol; 2018; 1856():87-101. PubMed ID: 30178247
[TBL] [Abstract][Full Text] [Related]
23. DNA methylation and breast cancer: A way forward (Review).
Vietri MT; D'Elia G; Benincasa G; Ferraro G; Caliendo G; Nicoletti GF; Napoli C
Int J Oncol; 2021 Nov; 59(5):. PubMed ID: 34726251
[TBL] [Abstract][Full Text] [Related]
24. Epigenome-Based Precision Medicine in Lung Cancer.
Kim D; Kim DH
Methods Mol Biol; 2018; 1856():57-85. PubMed ID: 30178246
[TBL] [Abstract][Full Text] [Related]
25. The emerging roles of NGS in clinical oncology and personalized medicine.
Hussen BM; Abdullah ST; Salihi A; Sabir DK; Sidiq KR; Rasul MF; Hidayat HJ; Ghafouri-Fard S; Taheri M; Jamali E
Pathol Res Pract; 2022 Feb; 230():153760. PubMed ID: 35033746
[TBL] [Abstract][Full Text] [Related]
26. Molecular biology as a tool for the treatment of cancer.
de Castro Sant' Anna C; Junior AGF; Soares P; Tuji F; Paschoal E; Chaves LC; Burbano RR
Clin Exp Med; 2018 Nov; 18(4):457-464. PubMed ID: 30006681
[TBL] [Abstract][Full Text] [Related]
27. Epigenomics and ovarian carcinoma.
Maldonado L; Hoque MO
Biomark Med; 2010 Aug; 4(4):543-70. PubMed ID: 20701443
[TBL] [Abstract][Full Text] [Related]
28. The value of epigenetic biomarkers in breast cancer.
Parrella P
Biomark Med; 2018 Sep; 12(9):937-940. PubMed ID: 30041537
[No Abstract] [Full Text] [Related]
29. DNA methylation aberrancies delineate clinically distinct subsets of colorectal cancer and provide novel targets for epigenetic therapies.
Weisenberger DJ; Liang G; Lenz HJ
Oncogene; 2018 Feb; 37(5):566-577. PubMed ID: 28991233
[TBL] [Abstract][Full Text] [Related]
30. Prognostic and Predictive Epigenetic Biomarkers in Oncology.
Kamińska K; Nalejska E; Kubiak M; Wojtysiak J; Żołna Ł; Kowalewski J; Lewandowska MA
Mol Diagn Ther; 2019 Feb; 23(1):83-95. PubMed ID: 30523565
[TBL] [Abstract][Full Text] [Related]
31. Pharmacogenomic biomarkers for personalized cancer treatment.
Rodríguez-Antona C; Taron M
J Intern Med; 2015 Feb; 277(2):201-217. PubMed ID: 25338550
[TBL] [Abstract][Full Text] [Related]
32. Cancer epigenomics: DNA methylomes and histone-modification maps.
Esteller M
Nat Rev Genet; 2007 Apr; 8(4):286-98. PubMed ID: 17339880
[TBL] [Abstract][Full Text] [Related]
33. Personalized medicine in gastric cancer: Where are we and where are we going?
Jácome AA; Coutinho AK; Lima EM; Andrade AC; Dos Santos JS
World J Gastroenterol; 2016 Jan; 22(3):1160-71. PubMed ID: 26811654
[TBL] [Abstract][Full Text] [Related]
34. Epigenetic mechanisms in endometrial cancer.
Stampoliou A; Arapantoni-Dadioti P; Pavlakis K
J BUON; 2016; 21(2):301-6. PubMed ID: 27273937
[TBL] [Abstract][Full Text] [Related]
35. Drugging the epigenome in the age of precision medicine.
Feehley T; O'Donnell CW; Mendlein J; Karande M; McCauley T
Clin Epigenetics; 2023 Jan; 15(1):6. PubMed ID: 36631803
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic Power of DNA Methylation Classifiers for Early Detection of Cancer.
Roy D; Tiirikainen M
Trends Cancer; 2020 Feb; 6(2):78-81. PubMed ID: 32061307
[TBL] [Abstract][Full Text] [Related]
37. Steps forward for cancer precision medicine.
Salgado R; Moore H; Martens JWM; Lively T; Malik S; McDermott U; Michiels S; Moscow JA; Tejpar S; McKee T; Lacombe D;
Nat Rev Drug Discov; 2018 Jan; 17(1):1-2. PubMed ID: 29170471
[TBL] [Abstract][Full Text] [Related]
38. Determining If a Somatic Tumor Mutation Is Targetable and Options for Accessing Targeted Therapies.
Bruinooge SS; Sherwood S; Grubbs S; Schilsky RL
J Oncol Pract; 2019 Nov; 15(11):575-583. PubMed ID: 31386607
[TBL] [Abstract][Full Text] [Related]
39. The potential for epigenetic analysis of paediatric CNS tumours to improve diagnosis, treatment and prognosis.
Sexton-Oates A; MacGregor D; Dodgshun A; Saffery R
Ann Oncol; 2015 Jul; 26(7):1314-24. PubMed ID: 25605740
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic Biomarkers for Environmental Exposures and Personalized Breast Cancer Prevention.
Park HL
Int J Environ Res Public Health; 2020 Feb; 17(4):. PubMed ID: 32069786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
